(Q35051309)

6 August 2017

1 reference

title

Allogeneic hematopoietic stem cell transplantation--yesterday, today, and tomorrow (English)

1 reference

6 August 2017

1

Rainer Storb

1 reference

PubMed ID

12543102

6 August 2017

language of work or name

1 reference

1 January 2003

1 reference

6 August 2017

Experimental Hematology

1 reference

6 August 2017

31

1 reference

6 August 2017

1

1 reference

6 August 2017

1-10

1 reference

IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Cytological Identification of Radiation-Chimæras

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Mortality and skin transplantability in x-irradiated mice receiving isologous, homologous or heterologous bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Implantation of functional erythropoietic elements following total-body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Circulating rat cells in lethally irradiated mice protected with rat bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

A compendium of reported human bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

The origin of dogs: running with the wolves

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Alteration of homograft reaction by A-methopterin in lethally irradiated mice treated with homologous marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Prevention of Delayed Foreign Marrow Reaction in Lethally Irradiated Mice by Early Administration of Methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Bone marrow transplantation in patients with thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Marrow transplantation in patients with thalassemia responsive to iron chelation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Bone marrow transplantation for sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Treatment of murine leukaemia with x-rays and homologous bone marrow. II

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Identical-twin bone marrow transplants for leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901020-2

7 January 2021

10.1016/S0301-472X(02)01020-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12543102